Gonorrhea Therapeutics Market
Gonorrhea Therapeutics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029
Analysis of Gonorrhea Therapeutics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Gonorrhea Therapeutics Market in Numbers:
- The gonorrhea therapeutics market recorded ~3% CAGR during the period, 2014 to 2018. Gonorrhea emerged as a public threat worldwide with increasing prevalence of the antibiotic-resistant strains, which sustained the demand for gonorrhea therapeutics in recent years.
- Revenues from gonorrhea therapeutics around the world is estimated at ~US$ 970 Mn in 2019, and record a 4% Y-o-Y over 2018. The gonorrhea therapeutics industry will remain sustained by inclination of the scientific community toward development of alternative therapies and new antibiotics.
- North America remains the most attractive market for gonorrhea therapeutics, primarily upheld by growing government initiatives to compact antibiotic resistance. The US government has released a plan to ‘Combat Antibiotic-Resistant Bacteria’ (CARB) that holds opportunistic potential for companies with strong regional presence.
- Research on the drug-resistance gonorrhea, which is likely to pave a potential pipeline for future treatment, is likely to favor the gonorrhea therapeutics industry.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competition Landscape
According to our study, the gonorrhea therapeutics market will remain a fairly fragmented landscape, with a large number of contenders collectively holding relatively greater shares than the frontrunners and competitors in the market. With ~40% market shares, the contenders are competing with product innovations in active therapy areas, targeted drug delivery, and capacity expansion to meet growing demand for therapeutics abreast escalating prevalence of gonorrhea.
Frontrunners in the gonorrhea therapeutics market are focusing more on diagnostic tests and services, and R&D dedicated to biosimilars and generics.
The stakeholders in the gonorrhea therapeutics market are more focused on strengthening their distribution in untapped markets, even as entering into strategic partnerships with local distributors to enhance their supplier force and propel sales.
Growing prevalence of antibiotic-resistant gonorrhea has meant that the need for new drugs is evident, as a significant chunk of the global demographic falls prey to the Neisseria gonorrhea bacteria annually. Although progress in gonorrhea vaccines has slugged in the past, recent advances allude an uptick, with conserved vaccine antigens that stimulate bactericidal antibodies being recognized.
New drug developments and laser-sharp focus on quick approvals will remain key winning imperatives for stakeholders in the gonorrhea therapeutics market, in turn complementing their brand repositioning strategies.
Prospects for the gonorrhea therapeutics market seem bullish, with key players increasingly vying for geographical presence, new drug launches, and stable supply chain logistics.
Key Factors Driving Growth in Gonorrhea Therapeutics Market
- Increasing prevalence of gonorrhea, coupled with the rising public awareness about STDs (Sexually-Transmitted Diseases), and advances in relevant diagnostic methods, are the key growth determinants of the gonorrhea therapeutics market.
- Rising incidence of gonorrhea has led to the advent of new diagnostic tests, such as nucleic acid amplification tests (NAATs), which enable early screening to keep the infection from spreading to the upper genital tract.
- Preference for NAATs over traditional cultures has grown significantly in recent years owing to their improved sensitivity and selectivity for Neisseria gonorrhoeae at rectal and oropharyngeal sites in men. Such increased availability and adoption of testing modalities is driving the demand for gonorrhea therapeutics.
- Low cost of gonorrhea therapeutics continues to favor its market prospects, while stakeholders eye to capitalize on the pricing value of widely used STD drugs, such as Ceftriaxone.
- Rapid improvements in healthcare infrastructure, particularly in developed regions are highly likely to create fresh growth avenues in the form of advanced and more effective drugs, thereby escalating the attractiveness of the gonorrhea therapeutics market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Key Challenges Faced by Stakeholders in Gonorrhea Therapeutics Market
- The advent of new antibiotic-resistant strains continues to impede the prospects of the gonorrhea therapeutics market by making the currently available drugs lose their effectiveness in fighting the bacterium. The insidious nature of gonorrhea, owing to its growing success at evolving to evade the antibiotics prescribed to treat remains a significant pain-point for stakeholders.
- The social stigma surrounding open discussions about STD, particularly in underdeveloped and developing countries has been hampering the true potential of the gonorrhea therapeutics market. Due to poor social acceptance of infection in line with the lack of openness and diverse communication regarding sexuality, the adoption of gonorrhea therapeutics is witnessing a restrictive growth.
Paramount Emphasis on Antibiotic R&D to Favor Gains
Antimicrobial resistance (AMR) has become a rapidly growing global public health threat. With AMR making more than 375 million annual new cases of sexually-transmitted infections (STIs) that are stringent to treat, there has emerged a dire need to tackle this upcoming health crisis.
The bacteria that causes gonorrhea is particularly prone to drug resistance, and is classed as ‘high priority’ for renewed antibiotic R&D by leading health organizations.
Turning into a global public health concern, in line with the high unmet need for gonorrhea treatment, growing prevalence of this infection has propelled organizations to collaborate and develop a novel treatment in this light.
For instance, Entasis Therapeutics and the Global Antibiotic Research & Development Partnership (GARDP) had collaborated to co-develop a new drug zoliflodacin, specifically to treat drug-resistant gonorrhea, while hoping to provide a solution.
Zoliflodacin is a new and first-in-class oral antibiotic that inhibits DNA synthesis in a different way than currently approved antibiotics. Zoliflodacin has been awarded fast track status by the FDA for development as oral treatment for gonorrhea infections, which is likely to translate into significant gains for the gonorrhea therapeutics market in the years to come.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Gonorrhea Therapeutics Market – Research Methodology
An authentic methodology and holistic approach lay the base of the actionable information mentioned in the report on gonorrhea therapeutics market. The Fact.MR study provides detailed information about the growth forecast of gonorrhea therapeutics market, along with an organized breakdown of the factors shaping the dynamics of the market.
Thorough primary and secondary has been employed to accumulate and present valuable insights into the projection analysis of gonorrhea therapeutics market. The report on gonorrhea therapeutics market has also passed through several validation tunnels to ensure that that insights covered in the report are exclusive and one of its kind.
Gonorrhea Therapeutics Market: Segmentation
-
Drug Type
- Macrolide Antibiotics (Azithromycin)
- Third-Generation Cephalosporin
- Cefixime
- Cefotaxime
- Ceftizoxime
- Ceftriaxone
- Cetriaxone
- Tetracycline Antibiotics (Doxycycline)
- Fluoroquinolones Antibiotics (Gemifloxacin)
- Aminoglycoside (Gentamicin)
- Aminocyclitol (Spectinomycin)
-
Route of Administration
- Oral
- Intra Muscular
-
Therapy Type
- Mono Therapy
- Dual Therapy
-
Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 4. Key Success Factors 5. Global Gonorrhea Therapeutics Market Demand (in Value US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029 5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018 5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Market Background 6.1. Macro-Economic Factors 6.1.1. Global GDP Growth Outlook 6.1.2. Global Healthcare Industry Market Outlook 6.2. Market Dynamics 6.2.1. Drivers 6.2.2. Restraints 6.2.3. Opportunity Analysis 7. Global Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029, by Region 7.1. Introduction 7.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018 7.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2029 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Middle East and Africa (MEA) 7.3.5. East Asia 7.3.6. South Asia 7.3.7. Oceania 7.4. Market Attractiveness Analysis By Region 8. Global Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2014 - 2018 8.3. Current and Future Market Size (US$ Mn) and Forecast By Drug Type, 2019-2029 8.3.1. Macrolide Antibiotics (Azithromycin) 8.3.2. Third-Generation Cephalosporin 8.3.2.1. Cefixime 8.3.2.2. Cefotaxime 8.3.2.3. Ceftizoxime 8.3.2.4. Ceftriaxone 8.3.2.5. Cetriaxone 8.3.3. Tetracycline Antibiotics (Doxycycline) 8.3.4. Fluoroquinolones Antibiotics (Gemifloxacin) 8.3.5. Aminoglycoside (Gentamicin) 8.3.6. Aminocyclitol (Spectinomycin) 8.4. Market Attractiveness Analysis By Drug Type 9. Global Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029, by Therapy Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Therapy Type, 2014 - 2018 9.3. Current and Future Market Size (US$ Mn) and Forecast By Therapy Type 2019-2029 9.3.1. Mono Therapy 9.3.2. Dual Therapy 9.4. Market Attractiveness Analysis By Therapy Type 10. Global Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029, by Route of Administration 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014 - 2018 10.3. Current and Future Market Size (US$ Mn) and Forecast By Route of Administration, 2019-2029 10.3.1. Oral 10.3.2. Intra Muscular 10.4. Market Attractiveness Analysis By Route of Administration 11. Global Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) By Distribution Channel, 2014 - 2018 11.3. Current and Future Market Size (US$ Mn) and Forecast By Distribution Channel, 2019-2029 11.3.1. Institutional Sales 11.3.1.1. Hospitals 11.3.1.2. Speciality Clinics 11.3.2. Retail Sales 11.3.2.1. Hospital Pharmacy 11.3.2.2. Retail Pharmacy 11.3.2.3. Mail Order Pharmacy 11.4. Market Attractiveness Analysis By Distribution Channel 12. North America Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2018-2029 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029 12.3.1. By Country 12.3.1.1. U.S. 12.3.1.2. Canada 12.3.2. By Drug Type 12.3.3. By Therapy Type 12.3.4. By Route of Administration 12.3.5. By Distribution Channel 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Drug Type 12.4.3. By Therapy Type 12.4.4. By Route of Administration 12.4.5. By Distribution Channel 13. Latin America Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Rest of Latin America 13.3.2. By Drug Type 13.3.3. By Therapy Type 13.3.4. By Route of Administration 13.3.5. By Distribution Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Drug Type 13.4.3. By Therapy Type 13.4.4. By Route of Administration 13.4.5. By Distribution Channel 14. Europe Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. Italy 14.3.1.3. France 14.3.1.4. U.K. 14.3.1.5. Spain 14.3.1.6. BENELUX 14.3.1.7. Russia 14.3.1.8. Rest of Europe 14.3.2. By Drug Type 14.3.3. By Therapy Type 14.3.4. By Route of Administration 14.3.5. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Drug Type 14.4.3. By Route of Administration 14.4.4. By Distribution Channel 15. South Asia Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Indonesia 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Drug Type 15.3.3. By Therapy Type 15.3.4. By Route of Administration 15.3.5. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Drug Type 15.4.3. By Therapy Type 15.4.4. By Distribution Channel 16. East Asia Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Drug Type 16.3.3. By Therapy Type 16.3.4. By Route of Administration 16.3.5. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Drug Type 16.4.3. By Therapy Type 16.4.4. By Route of Administration 16.4.5. By Distribution Channel 17. Oceania Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Drug Type 17.3.3. By Therapy Type 17.3.4. By Route of Administration 17.3.5. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Drug Type 17.4.3. By Therapy Type 17.4.4. By Route of Administration 17.4.5. By Distribution Channel 18. Middle East and Africa Gonorrhea Therapeutics Market Analysis 2014-2018 and Forecast 2019-2029 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. Turkey 18.3.1.3. Northern Africa 18.3.1.4. South Africa 18.3.1.5. Rest of Middle East and Africa 18.3.2. By Drug Type 18.3.3. By Therapy Type 18.3.4. By Route of Administration 18.3.5. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Drug Type 18.4.3. By Therapy Type 18.4.4. By Route of Administration 18.4.5. By Distribution Channel 19. Competition Analysis 19.1. Market Analysis by Tier of Companies (Gonorrhea Therapeutics) 19.2. Competition Dashboard 19.3. Competition Deep Dive 19.3.1. Bayer AG 19.3.1.1. Overview 19.3.1.2. Key Financials 19.3.1.3. Revenue Y-o-Y GROWTH 19.3.1.4. Key Development 19.3.1.5. Analyst Commentary 19.3.2. GlaxoSmithKline Plc. 19.3.2.1. Overview 19.3.2.2. Key Financials 19.3.2.3. Revenue Y-o-Y GROWTH 19.3.2.4. Key Development 19.3.2.5. Analyst Commentary 19.3.3. Pfizer Inc. 19.3.3.1. Overview 19.3.3.2. Key Financials 19.3.3.3. Revenue Y-o-Y GROWTH 19.3.3.4. Key Development 19.3.3.5. Analyst Commentary 19.3.4. Allergan plc 19.3.4.1. Overview 19.3.4.2. Key Financials 19.3.4.3. Revenue Y-o-Y GROWTH 19.3.4.4. Key Development 19.3.4.5. Analyst Commentary 19.3.5. Novartis AG 19.3.5.1. Overview 19.3.5.2. Key Financials 19.3.5.3. Revenue Y-o-Y GROWTH 19.3.5.4. Key Development 19.3.5.5. Analyst Commentary 19.3.6. Sanofi S.A. 19.3.6.1. Overview 19.3.6.2. Key Financials 19.3.6.3. Revenue Y-o-Y GROWTH 19.3.6.4. Key Development 19.3.6.5. Analyst Commentary 19.3.7. Mylan N.V. 19.3.7.1. Overview 19.3.7.2. Key Financials 19.3.7.3. Revenue Y-o-Y GROWTH 19.3.7.4. Key Development 19.3.7.5. Analyst Commentary 19.3.8. Teva Pharmaceutical Industries Ltd. 19.3.8.1. Overview 19.3.8.2. Key Financials 19.3.8.3. Revenue Y-o-Y GROWTH 19.3.8.4. Key Development 19.3.8.5. Analyst Commentary 19.3.9. Baxter International Inc. 19.3.9.1. Overview 19.3.9.2. Key Financials 19.3.9.3. Revenue Y-o-Y GROWTH 19.3.9.4. Key Development 19.3.9.5. Analyst Commentary 19.3.10. Hoffmann-La Roche Ltd. 19.3.10.1. Overview 19.3.10.2. Key Financials 19.3.10.3. Revenue Y-o-Y GROWTH 19.3.10.4. Key Development 19.3.10.5. Analyst Commentary 19.3.11. Merck & Co. 19.3.11.1. Overview 19.3.11.2. Key Financials 19.3.11.3. Revenue Y-o-Y GROWTH 19.3.11.4. Key Development 19.3.11.5. Analyst Commentary 20. Forecast Assumptions: Relevance and Impact 21. Assumptions and Acronyms Used 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
Table 02: Global Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Type
Table 2.1: Global Gonorrhea Therapeutic Market Volume (Tons and Units) Analysis 2014-2018 and Forecast 2019-2029, By Drug Type
Table 03: Global Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Therapy Type
Table 04: Global Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 05: Global Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 06: North America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 07: North America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 7.1: North America Gonorrhea Therapeutic Market Volume (Tons and Units) Analysis 2014-2018 and Forecast 2019-2029, By Drug Type
Table 08: North America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Therapy
Table 09: North America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 10: North America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 11: Latin America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 12: Latin America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 12.1: Latin America Gonorrhea Therapeutic Market Volume (Tons and Units) Analysis 2014-2018 and Forecast 2019-2029, By Drug Type
Table 13: Latin America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Therapy
Table 14: Latin America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 15: Latin America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 16: Europe Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 17: Europe Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 17.1: Europe Gonorrhea Therapeutic Market Volume (Tons and Units) Analysis 2014-2018 and Forecast 2019-2029, By Drug Type
Table 18: Europe Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Therapy
Table 19: Europe Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 20: Europe Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 21: South Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 22: South Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 22.1: South Asia Gonorrhea Therapeutic Market Volume (Tons and Units) Analysis 2014-2018 and Forecast 2019-2029, By Drug Type
Table 23: South Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Therapy
Table 24: South Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 25: South Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 26: East Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 27: East Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 27.1: East Asia Gonorrhea Therapeutic Market Volume (Tons and Units) Analysis 2014-2018 and Forecast 2019-2029, By Drug Type
Table 28: East Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Therapy
Table 29: East Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 30: East Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 31: Oceania Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 32: Oceania Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 32.1: Oceania Gonorrhea Therapeutic Market Volume (Tons and Units) Analysis 2014-2018 and Forecast 2019-2029, By Drug Type
Table 33: Oceania Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Therapy
Table 34: Oceania Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 35: Oceania Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 36: Middle East & Africa Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 37: Middle East & Africa Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 37.1: Oceania Gonorrhea Therapeutic Market Volume (Tons and Units) Analysis 2014-2018 and Forecast 2019-2029, By Drug Type
Table 38: Middle East & Africa Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Therapy
Table 39: Middle East & Africa Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 40: Middle East & Africa Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 41: China Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 42: China Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Therapy
Table 43: China Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 44: China Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 45: Japan Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 46: Japan Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Therapy
Table 47: Japan Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 48: Japan Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 49: India Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Type
Table 50: India Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Therapy
Table 51: India Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Route of Administration
Table 52: India Gonorrhea Therapeutic Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Gonorrhea Therapeutics Market Value Share 2018A, By Drug Type
Figure 02: Global Gonorrhea Therapeutics Market Value Share 2018A, By Therapy
Figure 03: Global Gonorrhea Therapeutics Market Value Share 2018A, By Route of Administration
Figure 04: Global Gonorrhea Therapeutics Market Value Share 2018A, By Distribution Channel
Figure 05: Global Gonorrhea Therapeutic Market Value Analysis and Forecast, 2017–2029 (US$ Mn)
Figure 06: Global Gonorrhea Therapeutic Market Value Opportunity Assessment, 2019-2029
Figure 07: Global Gonorrhea Therapeutic Revenue Share by Region, 2019E and 2029F
Figure 08: Global Gonorrhea Therapeutic Market Attractiveness Analysis, By Region, 2019E
Figure 09: Global Gonorrhea Therapeutic Revenue Share (in US$ Mn) by Drug Type, 2019E and 2029F
Figure 10: Global Gonorrhea Therapeutic Market Attractiveness Analysis, By Drug Type, 2019E
Figure 11: Global Gonorrhea Therapeutic Revenue Share by Therapy Type, 2019E and 2029F
Figure 12: Global Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy Type, 2019E
Figure 13: Global Gonorrhea Therapeutic Revenue Share by Route of Administration, 2019E and 2029F
Figure 14: Global Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration, 2019E
Figure 15: Global Gonorrhea Therapeutic Revenue Share by Distribution Channel, 2019E and 2029F
Figure 16: Global Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel, 2019E
Figure 17: North America Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type
Figure 18: North America Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 19: North America Gonorrhea Therapeutics Market Value Share 2019E, By Therapy
Figure 20: North America Gonorrhea Therapeutics Market Value Share 2019E, By Route of Administration
Figure 21: North America Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel
Figure 22: North America Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 23: North America Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 24: North America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis, 2014–2018
Figure 25: North America Gonorrhea Therapeutic Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 26: North America Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 27: North America Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 28: North America Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 29: North America Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 30: North America Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy
Figure 31: North America Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 32: North America Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration
Figure 33: North America Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 34: North America Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel
Figure 35: North America Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 36: Latin America Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type
Figure 37: Latin America Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 38: Latin America Gonorrhea Therapeutics Market Value Share 2019E, By Therapy
Figure 39: Latin America Gonorrhea Therapeutics Market Value Share 2019E, By Route of Administration
Figure 40: Latin America Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel
Figure 41: Latin America Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 42: Latin America Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 43: Latin America Gonorrhea Therapeutic Market Size (US$ Mn) Analysis, 2014–2018
Figure 44: Latin America Gonorrhea Therapeutic Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 45: Latin America Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 46: Latin America Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 47: Latin America Gonorrhea Therapeutic Market Attractiveness Analysis, By Drug Type
Figure 48: Latin America Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 49: Latin America Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy
Figure 50: Latin America Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 51: Latin America Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration
Figure 52: Latin America Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 53: Latin America Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel
Figure 54: Latin America Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 55: Europe Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type
Figure 56: Europe Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 57: Europe Gonorrhea Therapeutics Market Value Share 2019E, By Therapy
Figure 58: Europe Gonorrhea Therapeutics Market Value Share 2019E, By Route of Administration
Figure 59: Europe Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel
Figure 60: Europe Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 61: Europe Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 62: Europe Gonorrhea Therapeutic Market Size (US$ Mn) Analysis, 2014–2018
Figure 63: Europe Gonorrhea Therapeutic Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 64: Europe Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 65: Europe Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 66: Europe Gonorrhea Therapeutic Market Attractiveness Analysis, By Drug Type
Figure 67: Europe Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 68: Europe Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy
Figure 69: Europe Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 70: Europe Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration
Figure 71: Europe Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 72: Europe Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel
Figure 73: Europe Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 74: South Asia Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type
Figure 75: South Asia Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 76: South Asia Gonorrhea Therapeutics Market Value Share 2019E, By Therapy
Figure 77: South Asia Gonorrhea Therapeutics Market Value Share 2019E, By Route of Administration
Figure 78: South Asia Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel
Figure 79: South Asia Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 80: South Asia Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 81: South Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis, 2014–2018
Figure 82: South Asia Gonorrhea Therapeutic Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 83: South Asia Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 84: South Asia Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 85: South Asia Gonorrhea Therapeutic Market Attractiveness Analysis, By Drug Type
Figure 86: South Asia Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 87: South Asia Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy
Figure 88: South Asia Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 89: South Asia Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration
Figure 90: South Asia Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 91: South Asia Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel
Figure 92: South Asia Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 93: East Asia Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type
Figure 94: East Asia Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 95: East Asia Gonorrhea Therapeutics Market Value Share 2019E, By Therapy
Figure 96: East Asia Gonorrhea Therapeutics Market Value Share 2019E, By Route of Administration
Figure 97: East Asia Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel
Figure 98: East Asia Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 99: East Asia Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 100: East Asia Gonorrhea Therapeutic Market Size (US$ Mn) Analysis, 2014–2018
Figure 101: East Asia Gonorrhea Therapeutic Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 102: East Asia Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 103: East Asia Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 104: East Asia Gonorrhea Therapeutic Market Attractiveness Analysis, By Drug Type
Figure 105: East Asia Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 106: East Asia Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy
Figure 107: East Asia Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 108: East Asia Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration
Figure 109: East Asia Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 110: East Asia Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel
Figure 111: East Asia Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 112: Oceania Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type
Figure 113: Oceania Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 114: Oceania Gonorrhea Therapeutics Market Value Share 2019E, By Therapy
Figure 115: Oceania Gonorrhea Therapeutics Market Value Share 2019E, By Route of Administration
Figure 116: Oceania Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel
Figure 117: Oceania Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 118: Oceania Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 119: Oceania Gonorrhea Therapeutic Market Size (US$ Mn) Analysis, 2014–2018
Figure 120: Oceania Gonorrhea Therapeutic Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 121: Oceania Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 122: Oceania Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 123: Oceania Gonorrhea Therapeutic Market Attractiveness Analysis, By Drug Type
Figure 124: Oceania Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 125: Oceania Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy
Figure 126: Oceania Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 127: Oceania Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration
Figure 128: Oceania Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 129: Oceania Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel
Figure 130: Oceania Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 131: Middle East & Africa Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type
Figure 132: Middle East & Africa Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 133: Middle East & Africa Gonorrhea Therapeutics Market Value Share 2019E, By Therapy
Figure 134: Middle East & Africa Gonorrhea Therapeutics Market Value Share 2019E, By Route of Administration
Figure 135: Middle East & Africa Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel
Figure 136: Middle East & Africa Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 137: Middle East & Africa Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 138: Middle East & Africa Gonorrhea Therapeutic Market Size (US$ Mn) Analysis, 2014–2018
Figure 139: Middle East & Africa Gonorrhea Therapeutic Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 140: Middle East & Africa Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 141: Middle East & Africa Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 142: Middle East & Africa Gonorrhea Therapeutic Market Attractiveness Analysis, By Drug Type
Figure 143: Middle East & Africa Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 144: Middle East & Africa Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy
Figure 145: Middle East & Africa Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 146: Middle East & Africa Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration
Figure 147: Middle East & Africa Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 148: Middle East & Africa Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel
Figure 149: Middle East & Africa Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 150: Emerging Countries Gonorrhea Therapeutic Market Value Share (2019E)
Figure 151: Emerging Countries Gonorrhea Therapeutic Market Value (US$ Mn), By Key Countries, 2014A-2029E
Figure 152: China Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type
Figure 153: China Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 154: China Gonorrhea Therapeutics Market Value Share 2019E, By Therapy
Figure 155: China Gonorrhea Therapeutics Market Value Share 2019E, By Route of Administration
Figure 156: China Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel
Figure 157: China Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 158: China Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 159: China Gonorrhea Therapeutic Market Size (US$ Mn) Analysis, 2014–2018
Figure 160: China Gonorrhea Therapeutic Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 161: China Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 162: China Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 163: China Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy
Figure 164: China Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 165: China Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration
Figure 166: China Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 167: China Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel
Figure 168: China Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 169: Japan Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type
Figure 170: Japan Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 171: Japan Gonorrhea Therapeutics Market Value Share 2019E, By Therapy
Figure 172: Japan Gonorrhea Therapeutics Market Value Share 2019E, By Route of Administration
Figure 173: Japan Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel
Figure 174: Japan Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 175: Japan Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 176: Japan Gonorrhea Therapeutic Market Size (US$ Mn) Analysis, 2014–2018
Figure 177: Japan Gonorrhea Therapeutic Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 178: Japan Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 179: Japan Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 180: Japan Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy
Figure 181: Japan Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 182: Japan Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration
Figure 183: Japan Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 184: Japan Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel
Figure 185: Japan Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 186: India Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type
Figure 187: India Gonorrhea Therapeutics Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 188: India Gonorrhea Therapeutics Market Value Share 2019E, By Therapy
Figure 189: India Gonorrhea Therapeutics Market Value Share 2019E, By Route of Administration
Figure 190: India Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel
Figure 191: India Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 192: India Gonorrhea Therapeutics Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 193: India Gonorrhea Therapeutic Market Size (US$ Mn) Analysis, 2014–2018
Figure 194: India Gonorrhea Therapeutic Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 195: India Gonorrhea Therapeutic Market Attractiveness Analysis, By Country
Figure 196: India Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 197: India Gonorrhea Therapeutic Market Attractiveness Analysis, By Therapy
Figure 198: India Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 199: India Gonorrhea Therapeutic Market Attractiveness Analysis, By Route of Administration
Figure 200: India Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 201: India Gonorrhea Therapeutic Market Attractiveness Analysis, By Distribution Channel
Figure 202: India Gonorrhea Therapeutic Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the global Gonorrhea Therapeutics Market worth?
Revenues from gonorrhea therapeutics around the world is estimated at ~US$ 970 Mn in 2019, and record a 4% Y-o-Y over 2018.
What are the key markets for Gonorrhea Therapeutics Market?
North America, East Asia are the key markets for Gonorrhea Therapeutics Market
Gonorrhea Therapeutics Market